BioClinica currently works with hundreds of clinical research organizations and clinical trial outsourcing firms worldwide. Our clinical research organization partnerships with industry-leading technology and service companies expand the range of services available to our clients. Please view a list of our current CRO partners below.
Celebrating our 15th year, Novella Clinical is an active CRO partner to biopharmaceutical and medical device sponsors with experience spanning early phase through post-marketing development programs. Offering experienced teams, flexible solutions and transparency from the initial budgeting process through program execution, Novella is fully committed to quality and client satisfaction.
Since 1979, Axio Research has provided high quality data management, statistical and medical writing services for industry, government and academic sponsors in the clinical research field. Based in Seattle, Axio has participated in more than 400 industry-based clinical trials. The company also provides clinical trial design and clinical events committee support services, and serves as the independent statistical center for Data Monitoring Committees.
MMS Holdings, Inc.
MMS is a niche clinical research organization specializing in clinical programming, biostatistics, medical and regulatory writing, and comprehensive pharmacovigilance services. MMS is headquartered in Michigan with Asia operations in Bangalore, India. MMS is a highly experienced pharmaceutical service organization that is focused on quality deliverables. Senior leadership and much of the staff have over a decade of hands-on pharma experience including multiple submission experience. This commitment to quality deliverables, combined with robust submission experience, sets MMS apart from traditional service providers. MMS Holdings Inc. is ISO-9001:2008 certified for all services and maintains detailed quality metrics for every project. MMS works with BioClinica in understanding your clinical trial needs to optimize results, cost, and productivity on all levels. With impeccable attention to detail and experience you can trust, MMS is the best choice to support your project’s data output and reporting needs.
Beardsworth is a privately held contract research organization delivering research and business solutions for clinical trial programs since 1986. Our full range of services covers every aspect of the clinical trial process – from protocol development, project management, monitoring, data management, biostatistics & programming, regulatory consulting to the Clinical Study Report and NDA submission. Our continuing mission is to provide these services with consistently superior quality, on time and on budget. Focused on complicated trials in complex therapeutic areas, Beardsworth’s areas of expertise are oncology and vaccines. The increasing demands of Oncology and Vaccine research, individually and together, place Beardsworth in an attractive position given our many years of experience and patient-centric strategies for success in these two areas.
Beardsworth’s OncologyOne is a partnership with “best in class” regional CROs and technology providers offering unified strategies for global oncology trials. Global in reach and local in connection, OncologyOne combines the strategic benefits of a global CRO with the added flexibility of local oncology expertise.
Beardsworth is proud to be a WBENC-certified, women-owned business and registrant with CCR.
MedSource is recognized as a niche clinical research organization (CRO) focusing on providing support for the most complex clinical trials. Either working in a challenging therapeutic area or with a sophisticated trial design, our experienced team excels at delivering quality results for each and every project. With experience gained from over 400 clinical trials, MedSource has developed specific expertise in conducting oncology and early phase clinical trials in North America. MedSource began as a specialized clinical monitoring group and has consistently expanded to add services and staff to increase the value that we can deliver for our clients. Our services include clinical monitoring, clinical project management, regulatory affairs and submissions, QA auditing, study start-up services, feasibility and site selection, safety monitoring, and medical monitoring. We continue to focus on our core areas of expertise and partner with vendors we consider "best-in-class" to deliver a consolidated service offering to meet each clients individualized needs.
PRL Central Laboratory Services
PRL Central Laboratory Services one of the best kept secrets in the business, a great value with incredible service. We specialize in comprehensive diagnostic testing, with a focus on protocol requirements. We serve all phases of clinical research on a global basis, providing each client with accurate study set-up, timely results delivery and validated data management. Our credentialed and tenured laboratory professionals employ advanced clinical testing systems in a state-of-the-art facility. Comprehensive quality control and proficiency testing programs verify accuracy and reliability. PRL is operational 24 hours per day, 7 days per week, which provides the necessary flexibility to meet project needs and insure rapid results turnaround.
We excel in:
- Solutions Oriented Project Management
- Scientific Consultation Services
- Personalized Logistics Management
- Timely Laboratory Data Management/and Reporting
- Flexible Reporting Options
Health Sciences International, Inc.
Health Sciences International, Inc. (HSI) is a comprehensive clinical research organization (CRO) which was established in 1997. HSI has a unique business model which assures that Phase I-IV clinical trials meet milestone timelines while adhering to enforceable SOPs, GCP, Standards of the Industry and CFR/ ICH Guidelines. HSI specializes in cardiology, vascular disorders, endocrinology, internal medicine and CNS therapeutic areas. With worldwide capabilities that include: Protocol and CRF Design, Medical Affairs, Medical Monitoring, Clinical Operations, Project Management, Drug Research & Development, Safety and Pharmacovigilance, Ambulatory BP & EKG Monitoring, Medical Writing, Medical Science Liaisons, Data Management and Biostatistics, Site Selection and Feasibility, REMS/ registry/Health Outcome Systems creating customized and intelligent solutions that assure deliverables to meet the goals of our clients while reducing time to market and overhead expenses. HSI has a commitment to patient safety through professional Educational Marketing and supportive direct to consumer capabilities, conferences, seminars and CME/ CEU accreditation. HSI has a stellar reputation in the industry that excels in Leadership, Integrity, Vision and Excellence (LIVE) and prides itself with “first-rate” collaborative partners such as BioClinica.
Kaizen Clinical Services, Inc.
Kaizen Clinical Services is a woman owned contract research organization founded in 2007 with a focus on oncology. Our founding principle that still guides us today is to provide an alternative approach to meet the outsourcing needs of the pharmaceutical and biotechnology industries particularly as it relates to oncology trials, our area of greatest experience. Kaizen personnel have managed and/or monitored Phase I – Phase IV trials that enrolled between 35 and 2,500 patients.
Kaizen offers project management, clinical monitoring, consulting and training services provided by well-experienced directors, managers and monitors. Our staff is a blend of permanent employees and contract consultants in a ratio of 80/20. We believe this ratio provides the depth of company experience necessary for successful execution of a program while maintaining the flexibility required to rapidly and seamlessly meet your outsourcing needs.
Our operational philosophy is to fully integrate our staff into your operational units and for Kaizen executives to be directly involved in dealing with emerging issues and participating in project specific communications. The goal of Kaizen Clinical Services is provide high quality services to help assure the success of your clinical trial.
Symbiance began operations in 1990 to provide clear, precise and timely solutions for the data needs of clinical trial professionals. As a leading contract research organization with proven expertise in delivering innovative data solutions for pharmaceutical and biotechnology companies, Symbiance is committed to innovative and precise results that will allow clients to bring drugs to market quickly, accurately and cost effectively. Symbiance includes a clinical data management unit, biostatistical analysis, and SAS programming divisions supporting Phase I through IV clinical trials. For more information, please visit www.symbiance.com.